Radar › Companies › Life Sciences Platforms and Tools · Victoria
Radar · Life Sciences Platforms and Tools in Victoria

Best Life Sciences Platforms and Tools Companies in Victoria, Australia

The 34 best Life Sciences Platforms and Tools companies in Victoria, Australia in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: PolyActiva.

34companies tracked
$31.5Mdisclosed funding
0unicorns
6have raised
FLIAR INTELLIGENCE · LIFE SCIENCES PLATFORMS AND TOOLS × VICTORIA

Our analysis of 50 Life Sciences Platforms and Tools companies

$4.8b in tracked funding; 68% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.

50companies analysed
68%cloud-native stacks
2025funding peak (by rounds)
2unicorns
2013median founding year

Ranked: Best Life Sciences Platforms and Tools companies in Victoria

#CompanyDisclosed fundingLast roundStageFounderFoundedTech stackPatents & IP focusRecent signals
1PolyActiva
Drug delivery platform
$24M16 mo agoSeries C—2010———
2Cincera Therapeutics
Drug discovery platform
$6M104 mo agoSeries AStuart Pitson
Co-Founder
2018—13 patents
Small-molecule DES1 enzyme inhibitors for antifibrotic therapeutic applications.
—
3Tiny Bright Things
Provider of microscopy tools for image and measurement
$2M47 mo agoSeedRaymond Dagastine
Co-Founder & CEO
2020———
4Zip Diagnostics
Developer of molecular diagnostic tests and instruments for infectious diseases
$750K66 mo agoFunding RaisedJack Richards
Co-Founder
2019Wix eCommerceCart FunctionalityWix+207 patents
Rapid lateral‑flow immunoassay devices for point‑of‑care biological and environmental testing
—
5MiniFAB
Developing and Manufacturing Polymer Micro-Engineered Products
$102K108 mo agoAcquired—2002———
6Affinity Bio
Develops antibodies for cancer therapeutics
——DeadpooledPeter Smith
CEO
2009———
7Allele Microbiome
Provides DNA based microbiol screening test of gut, oral, soil and food samples
——DeadpooledKriben Govender
Co-Founder & MD
2017———
8Amplia Therapeutics
Developer of therapies for treating cancer and pulmonary fibrosis
——PublicChris Burns
Co-Founder & Director
2000SentryTypeScriptGraphQL+1624 patents
FAK inhibitor salt/crystal formulations and combination therapies for pulmonary fibrosis treatment
—

Top 5 Life Sciences Platforms and Tools companies in Victoria

#1
Series C · Melbourne, Victoria · founded 2010 · 27 employees
$23.6Mraised
▾

PolyActiva has developed a platform technology for slow-release, site-specific drug delivery. Upon the application of the treatment, complete erosion of the implant occurs leaving no residue following drug release. This technology can be used to produce new biomedical products, drug-delivery devices and device components that enable delivery of drugs directly to the affected organ or treatment site. They are produced from a proprietary drug-polymer conjugate technology. Products are being developed for glaucoma, endophthalmitis, and osteoarthritis.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 2k LinkedIn followers — 5.7% of this cohort's audience
Activity: 1 partnerships (incl. ReserveSight Inc.) announced in 12 mo
Funding rounds
  • May 2025Series C$25.7M
  • Sep 2018Series B$11.5M
  • Feb 2013Series B$9.5M
  • Jan 2011Series A—
Investors
Medical Research Commercialisation Fund, Yuuwa Capital, Brandon Capital, National Reconstruction Fund
#2
Seed · Melbourne, Victoria · founded 2020 · 5 employees
$1.5Mraised
▾

Provider of microscopy tools for image and measurement. The company offers Halo Element is a microscope attachment that enables imaging and measurement down to the scale of viruses, drug particles, and nanotubes.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 852 LinkedIn followers
Activity: 1 awards announced in 12 mo
Funding rounds
  • Nov 2022Seed$1.5M
Founders & team
Raymond DagastineCo-Founder & CEO
Investors
Uniseed, University of Melbourne
#3
Series A · Melbourne, Victoria · founded 2018 · 3 employees
$5.5Mraised
▾

Cincera therapeutics is a spin-off from Monash Institute of Pharmaceutical Sciences (MIPS) at Monash University (Monash) in Melbourne. It has drug discovery platform based on the discovery of Professor Bernard Flynn and Professor Stuart Pitson, from the Centre for Cancer Biology for developing small molecules against non-alcoholic steatohepatitis. The company also develops small molecule drugs aiming to treat difficult-to-treat inflammatory and fibrotic conditions associated with obesity and metabolic disorders, with potential applications in many other disease areas including cancer.

Funding rounds
  • Feb 2018Series A$5.5M
Founders & team
Stuart PitsonCo-Founder
Investors
Medical Research Commercialisation Fund, Brandon BioCatalyst, Brandon Capital
#4
Funding Raised · Collingwood, Victoria · founded 2019
$750Kraised
▾

Developer of molecular diagnostic tests and instruments for infectious diseases. The company is developing a sensitivity molecular test system for SARS-CoV-2 and sexually transmitted diseases.

Funding rounds
  • Apr 2021Grant (prize money)$750K
Founders & team
Jack RichardsCo-Founder
Investors
business.gov.au
#5
Acquired · Scoresby, Victoria · founded 2002 · 150 employees
$102Kraised
▾

MiniFAB is focused on the development and manufacture of disposable polymer microfluidic and microengineered products. The company offers client specified solutions to a variety of markets including diagnostics and medical devices, environmental monitoring, food packaging and aerospace. It offers services including translation of design concepts into working prototypes, product development, and Contract OEM & ODM manufacturing.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 8k LinkedIn followers — 18.0% of this cohort's audience
Funding rounds
  • Oct 2017Grant (prize money)$102K
Investors
Invest Victoria
Tech stack
JoomlaPhpBootstrapVimeoHelix UltimateAnimate.Css

Funding & investor landscape

$31.5Mtotal disclosed funding
5companies funded
7disclosed rounds
0rounds last 90 days
Most active investors
Brandon Capital2 rounds
Leading Technology Group2 rounds
Medical Research Commercialisation Fund2 rounds
Brandon BioCatalyst1 rounds
Dragonfly Enviro Capital1 rounds
FoodBytes1 rounds
Gunnersen Investments1 rounds
Invest Victoria1 rounds
National Reconstruction Fund1 rounds
Uniseed1 rounds
Prism market signals · Australia · country-scoped Prism corpus, 3,463,022 docs

Market landscape — 10 sub-themes by coverage

Share of Life Sciences Platforms and Tools coverage by sub-theme.

Regulatory-risk over time rising

Funding & growth over time

funding rising · growth rising

RESEARCH IN VICTORIA · Health & Bio

How research on Bioinformatics in Victoria is moving

A read on the academic research around Bioinformatics in Victoria — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 42 papers.

42 papers · stance +0.40 · 34% breakthrough · 23% concern
breakthrough · advancement · concern
top institutions
  • University of Victoria14
  • Victoria University of Wellington4
  • Bahawal Victoria Hospital4
  • Victorian Comprehensive Cancer Centre3
  • The Royal Victorian Eye & Ear Hospital3
leading researchers
Graeme K. Knowles · Iona M. MacLeod · Jacob J. Imbery · Mark Louie Lopez · Michael J. Allison · Neha Acharya‐Patel
prism intelligence · tone & topics
88% positive · 0% critical tone
HealthPharmaceuticalsBiotechnologyMedical ResearchBiologyHealthcare
▲ Breakthroughs12 · 29%
▲ 0%→28% share
0 median citations92% since 2021mostly methods-led
Breakthroughs are rising (0%→28% of field), led by GenBank.
rising sub-themes (early→recent)
  • GenBank2
  • Environmental DNA2
  • Mitochondrial DNA2
  • Biodiversity2
  • Taxon2
Landmark BioPortal: ontologies and integrated data resources at the click of a mouse · 877 cites
◆ Advancements15 · 36%
▲ 0%→38% share
0 median citations100% since 2021mostly reviews
Advancements are rising (0%→38% of field), led by Breast cancer.
rising sub-themes (early→recent)
  • Breast cancer2
  • Biomarker2
  • Disease2
  • Population2
  • Context (archaeology)2
Landmark The Zinc Finger Ran-Binding Protein 3 (ZRANB3): An Advanced Perspective · 1 cites
▼ Concerns8 · 19%
▲ 0%→18% share
0 median citations88% since 2021mostly reviews
Concerns are rising (0%→18% of field), led by Population.
rising sub-themes (early→recent)
  • Population2
  • Identification (biology)2
  • Inheritance (genetic algorithm)1
  • Epigenetics1
  • Genome1
Landmark Who is eating what: diet assessment using next generation sequencing · 1,284 cites

Common questions

How many Life Sciences Platforms and Tools companies are there in Victoria, Australia?
Radar tracks 34 indexable Life Sciences Platforms and Tools companies headquartered in Victoria, Australia that meet our profile-completeness bar.
What is the total funding raised by Life Sciences Platforms and Tools companies in Victoria, Australia?
The Life Sciences Platforms and Tools companies in Victoria, Australia on this list have raised a combined $31.5M in disclosed equity funding across 5 funded companies.
Which is the highest-funded Life Sciences Platforms and Tools company in Victoria, Australia?
PolyActiva is the highest-funded Life Sciences Platforms and Tools company in Victoria, Australia, with $23.6M in disclosed equity funding.
How many Life Sciences Platforms and Tools companies in Victoria, Australia are funded?
5 of the 34 Life Sciences Platforms and Tools companies in Victoria, Australia on this list have disclosed at least one equity funding round.
How many Life Sciences Platforms and Tools unicorns are there in Victoria, Australia?
None of the Life Sciences Platforms and Tools companies in Victoria, Australia on this list currently has a disclosed valuation of $1B or more.
Who are the top investors in Victoria, Australia Life Sciences Platforms and Tools companies?
The most active investors in Victoria, Australia Life Sciences Platforms and Tools companies on this list include Brandon Capital, Leading Technology Group, Medical Research Commercialisation Fund, Brandon BioCatalyst, Dragonfly Enviro Capital.
Rohit KhannaTrends & Stories

Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.

Coming soon